Inventor
BASTO PAMELA
US20 patents
⚠️ This page may combine multiple inventors who share the name “BASTO PAMELA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MASSACHUSETTS INST TECHNOLOGY
10 patentsUS9474717B2Oct 25, 2016
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY33 citations97
US9439859B2Sep 13, 2016
Adjuvant incorporation in immunoanotherapeutics
MASSACHUSETTS INST TECHNOLOGY34 citations97
US9308280B2Apr 12, 2016
Targeting of antigen presenting cells with immunonanotherapeutics
MASSACHUSETTS INST TECHNOLOGY45 citations97
US8343498B2Jan 1, 2013
Adjuvant incorporation in immunonanotherapeutics
MASSACHUSETTS INST TECHNOLOGY51 citations97
US9233072B2Jan 12, 2016
Adjuvant incorporation in immunonanotherapeutics
MASSACHUSETTS INST TECHNOLOGY27 citations94
US9539210B2Jan 10, 2017
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY27 citations93
US11111472B2Sep 7, 2021
Delivery of biomolecules to immune cells
MASSACHUSETTS INST TECHNOLOGY19 citations90
US9526702B2Dec 27, 2016
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY4 citations83
US11547667B2Jan 10, 2023
Vaccine nanotechnology
MASSACHUSETTS INST TECHNOLOGY1 citations72
US12410392B2Sep 9, 2025
Delivery of biomolecules to immune cells
MASSACHUSETTS INST TECHNOLOGY0 citations59
IANNACONE MATTEO
3 patentsUS8277812B2Oct 2, 2012
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
IANNACONE MATTEO45 citations97
US8932595B2Jan 13, 2015
Nicotine immunonanotherapeutics
IANNACONE MATTEO33 citations93
US8906381B2Dec 9, 2014
Immunonanotherapeutics that provide IGG humoral response without T-cell antigen
IANNACONE MATTEO31 citations92